Indefinite Delivery Contract 36C25522D0055
Award Date 9/1/22
Last Date to Order 8/31/26
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Sofie Co. was awarded an indefinite delivery contract from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to provide radiopharmaceuticals. The contract has a potential value of $209,760 and period of performance through July 2022. Sofie was issued two firm fixed price delivery orders against the VHA Pharmaceutical Prime Vendor contract totaling $537,032.67 to supply Pylarify Piflufolastat F18 for use in positron emission tomography...
- Sofie CO. has been awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide radioactive PET tracer isotopes. The single award contract has a potential value of $1,698,000 and period of performance through February 2029. Under the contract, Sofie CO. has received a $339,600 firm fixed price delivery order to supply radioactive PET tracer isotopes for use at the Veterans Affairs Medical Center...
- This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $2,345,668 Firm Fixed Price contract has an ultimate completion date of August 31, 2029 and was awarded on September 1, 2024. The contract is for the delivery of PYLARIFY (piflufolastat F-18) isotopes, which are used for prostate cancer detection through positron emission...
- The Department of Veterans Affairs Veterans Integrated Service Network 10 (VA VISN 10) awarded a single-award indefinite delivery contract to Sofie CO., a subsidiary of Sofie Biosciences, to provide radiopharmaceutical PET imaging products and services. The $1.3 million contract, with a period of performance from October 2021 through September 2026, supports the VA's diagnostics and cancer treatment programs for veterans across the VISN 10 region. The contract requires Sofie to deliver...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA-VHA) awarded a single-award, indefinite delivery contract to Sofie CO., doing business as Sofie, to provide PET radiopharmaceuticals. The contract includes a base period from April 15, 2022 to April 14, 2025 with a potential value of $676,598.52. Two firm fixed price delivery orders were also awarded against the contract to provide PET radiopharmaceuticals to the VA Western New York...
- The key products and services being delivered under this federal contract IDV award are specialized radiopharmaceuticals and related services for medical imaging and cancer treatment. The prime contractor is Sofie CO., a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals. The contract IDV, valued at $5,864,170, was awarded by the Department of Veterans Affairs (VA) Veterans Integrated...
- The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Sofie CO., doing business as Sofie and subsidiary of Sofie Biosciences, Inc., to provide radiopharmaceutical products and services in support of nuclear medicine diagnostic services for veterans. The single award contract, valued at up to $500,000, has a period of performance from October 1, 2022 through March 31, 2024. Two calls have been issued against the blanket purchase agreement. The...
- This federal contract IDV, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2, is for the supply of PET radiopharmaceuticals to the Buffalo VA Medical Center. The $1.9 million single-award IDV was granted to Sofie CO., a for-profit subsidiary of Sofie Biosciences, Inc. that specializes in radiopharmaceuticals and PET imaging agents. The initial $635,896.40 delivery order under this IDV covers the supply of five specific radiopharmaceuticals: FDG, Cu64...
- The federal contract IDV award in this case was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The IDV has a ceiling value of $6,282,459.40 and is focused on the procurement of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection, as well as other PET imaging agents such as FDG (fluorodeoxyglucose) and NEURACEQ (florbetaben F-18). The IDV has facilitated...
- Sofie CO. has been awarded a blanket purchase agreement by the Defense Health Agency to provide radiopharmaceuticals to various military treatment facilities. The single award BPA has a potential value of $700,000 and period of performance through September 2025. Sofie will supply specialized molecular imaging agents to support diagnostic imaging programs at locations including Fort Sam Houston in Texas. Three calls have been placed against the BPA. In September 2023, Sofie received a $40,800...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C25522D0055-36C25524N0317 | Sofie CO. | $216.5k | 9/1/24 | 8/31/25 | 8/8/24 | |
Delivery Order 36C25522D0055-36C25523N0378 | Sofie CO. | $209.3k | 9/1/23 | 8/31/24 | 11/8/23 | |
Delivery Order 36C25522D0055-36C25525N0412 | Sofie CO. | $216.5k | 9/1/25 | 8/31/26 | 8/22/25 | |
Delivery Order 36C25522D0055-36C25522N0410 | Sofie CO. | $125.4k | 9/1/22 | 1/26/24 | 1/25/24 |